Nicotinamide Adenine Dinucleotide (NAD+), 500 mg. Sterile lyophilised powder, manufactured in the EU under GMP conditions. For professional use only — not a ready-to-administer product. Intended for further processing by qualified personnel.
AWORIS
NAD+
Please sign in to your account and upload your profesional license document to view prices.
Specifications
- Active Ingredient: NAD+ (CAS No. 53-84-9)
- Form: Sterile lyophilized powder
- Content: 500 mg per vial
- Purity: >95%
- HS Code: 2934999090
- Manufacturing: Europe (EU standards)
Storage & Stability
- Store in the dark at 2–8 °C
- Shelf life: up to 24 months from date of batch certificate
Ingredients
- Nicotinamide Adenine Dinucleotide (NAD+) >95%
INTENDED USE
Supplied as a raw material for further processing by qualified healthcare professionals. Not intended for direct application to humans or distribution to end consumers.
Manufactured in Europe
Clinical-grade
EU-wide delivery
FAQ
1. What is AWORIS NAD+?
AWORIS NAD+ is Nicotinamide Adenine Dinucleotide (NAD+), 500 mg per vial, supplied as a sterile lyophilised powder. It is manufactured in the EU under GMP conditions and intended exclusively for further processing by qualified professionals.
2. Who can purchase this product?
AWORIS products are available exclusively to verified licensed professionals, clinics and commercial processing. Verification of professional credentials or a valid business license is required before pricing and ordering access is granted.
3. Is this product ready to administer?
No. AWORIS NAD+ is supplied as a lyophilised raw material powder for further processing by qualified personnel. Lyophilisation (freeze-drying) is a standard pharmaceutical process for substances that are unstable in solution over time. The powder form allows for longer shelf life and is reconstituted at the point of use.
4. Where is it manufactured?
In the European Union (Italy), under GMP (Good Manufacturing Practice) conditions. Full batch documentation is provided with each delivery.
5. Is a Certificate of Analysis provided?
Yes. Every batch is supplied with a Certificate of Analysis documenting purity, sterility, and other specifications. CoAs are available on.
6. How should the product be handled after reconstitution?
After reconstitution, store at 2–8 °C, protected from light. Use within 28 days. Reconstitution should be performed by qualified personnel under appropriate conditions.
7. How is the product shipped?
Shipping at room temperature is permitted for the unopened product. Refrigerated storage (2–8 °C) is required upon receipt.
8. What if I have questions about clinical use, dosing, or reconstitution protocols?
Clinical decisions regarding use, dosing, reconstitution, and administration are the responsibility of the qualified healthcare professional. AWORIS does not provide clinical guidance. Please refer to your own professional judgment and the product documentation supplied with each batch.
See More of our formulas
